Benitec Ltd   Report issue

For profit Phase 2
Founded: Melbourne VIC Australia (2001)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2018
NCT03433027
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Benitec Biopharma, Inc. | Benitec BioPharma Ltd

Active Ingredients

Drugs in Phase 2 Trials (3)

Key: Benitec Ltd (2) Acquired (1)

bb-301 (1 trial)

bb-401 (1 trial)

tt-034 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3